Found: 7
Select item for more details and to access through your institution.
Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193672
- By:
- Publication type:
- Article
Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085387
- By:
- Publication type:
- Article
Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179124
- By:
- Publication type:
- Article
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2420, doi. 10.3390/jcm10112420
- By:
- Publication type:
- Article
Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity.
- Published in:
- Journal of Molecular Cell Biology, 2016, v. 8, n. 2, p. 178, doi. 10.1093/jmcb/mjw003
- By:
- Publication type:
- Article
The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance inmyocarditis.
- Published in:
- European Heart Journal, 2018, v. 39, n. 10, p. 876, doi. 10.1093/eurheartj/ehx624
- By:
- Publication type:
- Article
Metformin Attenuates ROS via FOXO3 Activation in Immune Cells.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.581799
- By:
- Publication type:
- Article